# Non-targeted metabolite profiling reveals substantial equivalence of omega-3 enriched PfFAD3-1 transgenic soybeans

## TL;DR

This study shows that transgenic soybeans with increased omega-3 content are compositionally safe and similar to non-GM soybeans.

## Contribution

The study introduces non-targeted metabolite profiling as a robust method for assessing the safety of nutritionally enhanced GM soybeans.

## Key findings

- Environmental factors strongly influence metabolite composition in transgenic soybeans.
- Most metabolites in transgenic soybeans remain within natural variation ranges of non-GM soybeans.
- Increased β-amyrin and soyasaponin I levels are consistent with metabolic pathway interactions.

## Abstract

The overexpression of the Physaria fendleri ω-3 fatty acid desaturase (PfFAD3-1) in soybean (Glycine max (L.) Merr.) substantially increases seed α-linolenic acid (18:3) content. To evaluate the compositional safety of PfFAD3-1 transgenic soybeans, we conducted a three-year, two-location field trial (Jeonju and Gunwi, Republic of Korea) and applied non-targeted metabolite profiling of polar and lipophilic metabolites. Multivariate analyses (PCA, PLS-DA) revealed that environmental factors (site and year) had a strong effect on seed metabolite composition. Volcano plot and variable importance in projection (VIP) analyses indicated that most metabolite differences between PfFAD3-1 lines and Kwangan (KA) varied across years and locations, reflecting gene – environment interactions. Importantly, the majority of metabolites in PfFAD3-1 lines remained within the natural variation range of non-GM reference cultivars, supporting substantial equivalence. The consistent deviation was an increase in β-amyrin, a triterpenoid precursor of soyasaponins. LC – MS analysis further confirmed line- and environment-dependent increases in specific saponins, particularly soyasaponin I. Given the established safety of triterpenoids in soybean and the biological coherence of fatty acid – triterpenoid pathway cross-talk, these findings suggest that β-amyrin accumulation represents an intended metabolic adjustment rather than an unintended effect. Collectively, our results demonstrate that non-targeted metabolomics complements conventional OECD-recommended compositional analyses, providing a robust framework for the safety assessment of nutritionally enhanced GM soybeans.